Recombinant Human PLK3 Polo Box Domain Protein，His & MBP

The Polo-like kinase 3 (PLK3) is a member of the Polo-like kinase family, which is known for its critical role in regulating cell cycle progression and various cellular processes. The Polo Box Domain (PBD) of PLK3 is particularly interesting, as it is responsible for binding to specific phosphorylated substrates and facilitating their subsequent phosphorylation by the kinase. Understanding the structure and function of PLK3 and its PBD has significant implications for cancer research, as aberrant expression or activity of PLK3 is linked to tumorigenesis and progression. Researchers are increasingly focused on characterizing the PBD to elucidate its role in substrate recognition and specificity. Recombination technology enables the production of PLK3 PBD as a recombinant protein, allowing scientists to study its interactions in vitro. This research can lead to insights into how PLK3 contributes to cellular signaling pathways and may uncover new therapeutic targets for cancer treatment. Additionally, investigating the PBD may help in designing small molecules that can modulate PLK3 activity, providing novel avenues for intervention in cancers where PLK3 is dysregulated. The ongoing exploration of PLK3 and its Polo Box Domain thus represents a promising frontier in the pursuit of targeted cancer therapies and a deeper understanding of cell cycle regulation.